688321 微芯生物
2025/09 - 九个月2024/122023/122022/122021/12

盈利能力分析
净资产收益率 ROE (%)4.372-6.9635.5091.1921.508
总资产报酬率 ROA (%)2.056-3.5502.9130.7301.213
投入资产回报率 ROIC (%)2.283-3.9093.3360.8561.363

边际利润分析
销售毛利率 (%)87.29086.70689.12294.34194.987
营业利润率 (%)10.443-27.13018.5353.0145.171
息税前利润/营业总收入 (%)12.666-12.52721.5883.4184.008
净利润/营业总收入 (%)10.497-17.4139.3922.4185.101

收益指标分析
经营活动净收益/利润总额(%)108.98780.209-201.58222.558-62.583
价值变动净收益/利润总额(%)-23.71522.335290.69515.83229.661
营业外收支净额/利润总额(%)-0.120-84.572-0.055-5.388-19.676

偿债能力分析
流动比率 (X)1.8692.4012.8922.1912.174
速动比率 (X)1.7942.3102.7712.1382.122
资产负债率 (%)54.42351.36446.62045.58725.168
带息债务/全部投入资本 (%)44.52942.10134.16729.8494.267
股东权益/带息债务 (%)114.646127.070172.198209.8781,993.300
股东权益/负债合计 (%)83.74494.688114.500114.800297.323
利息保障倍数 (X)5.664-5.7697.0496.129-12.816

营运能力分析
应收账款周转天数 (天)85.93297.360120.07389.98363.936
存货周转天数 (天)148.907181.037238.879263.140231.585